Chester County News and Community Website
WAYNE, PA — Aclaris Therapeutics, Inc. (NASDAQ: ACRS) has announced significant findings about ATI-2138, a novel investigational drug that acts as a covalent inhibitor of two key immune signaling kinases, ITK …
Aclaris Therapeutics Unveils Promising Data on ATI-2138, a Novel Dual ITK/JAK3 Inhibitor Read More
MALVERN, PA — MAXONA Pharmaceuticals has officially emerged from stealth mode, announcing the successful completion of its U.S. Phase 1 clinical trials for MAX-001, a groundbreaking non-opioid, non-NSAID oral therapy designed …
MAXONA Pharmaceuticals Completes Phase 1 Trials for Breakthrough Pain Therapy Read More
WAYNE, PA — Palvella Therapeutics, Inc. (Nasdaq: PVLA) announced the expansion of SELVA, its Phase 3 clinical trial of QTORIN™ 3.9% rapamycin anhydrous gel (QTORIN™ rapamycin), to include children as young …
Palvella Therapeutics Expands Phase 3 Trial to Younger Patients Read More
WAYNE, PA — Silver Lining Clinics LLC, a subsidiary of MoodRx LLC, is set to launch its revolutionary mental health service for seniors on February 14, 2025. Designed to address critical …
Silver Lining Clinics Launches Medicare-Covered Therapy for Seniors Read More
WASHINGTON, D.C. — The U.S. Food and Drug Administration (FDA) has issued a safety communication warning users of smartphone-compatible diabetes devices about potential risks stemming from missed or undelivered alerts. …
Stay Alert: FDA Warns Diabetes Patients About Smartphone Device Risks Read More
PHILADELPHIA, PA— Researchers at The Wistar Institute, led by Jessie Villanueva, Ph.D., have made significant strides in combating treatment-resistant melanoma. Their latest discovery focuses on inhibiting the gene S6K2, a breakthrough …
Wistar Institute Uncovers New Strategy for Treating Resistant Melanoma Read More
MALVERN, PA — Annovis Bio Inc. (NYSE: ANVS) has initiated its pivotal Phase 3 clinical trial evaluating buntanetap as a treatment for early Alzheimer’s disease (AD), marking an important step forward …
Annovis Bio Launches Phase 3 Trial for Alzheimer’s Drug Buntanetap Read More
WASHINGTON, D.C. — The U.S. Food and Drug Administration (FDA) has approved Journavx (suzetrigine) 50 milligram oral tablets, a groundbreaking non-opioid analgesic designed to treat moderate to severe acute pain …
FDA Approves First-in-Class Non-Opioid Pain Drug Journavx Read More
WEST CHESTER, PA — Pennsylvania state leaders convened on Friday for a groundbreaking roundtable to address the critical intersection of maternal health and substance use disorders (SUD). The discussion, hosted by …
How Pennsylvania’s Bold Action on Maternal Health and Addiction Could Change Lives Forever Read More
WEST CHESTER, PA — West Chester Rehabilitation & Healthcare Center has introduced a Cardiac Rehabilitation program designed to enhance recovery and quality of life for heart patients. This new initiative focuses …
West Chester Rehabilitation & Healthcare Center Launches Cardiac Rehab Program Read More